跳至主要内容
临床试验/NCT04899180
NCT04899180已完成早期 1 期

Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis: A Community Study

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2023年7月14日最近更新:
适应症
干预措施

试验速览

阶段
早期 1 期
状态
已完成
发起方
Mayo Clinic
入组人数
4
试验地点
1
主要终点
Prevalence of TTR-CA in patients with moderate and severe aortic stenosis

研究概览

简要总结

The purpose of this study is to determine the prevalence of transthyretin cardiac amyloidosis (TTR-CA) among patients with moderate and severe aortic stenosis in Southeast Minnesota using 99mTc-PYP single-photon positive emission computed tomography with computed tomography (SPECT/CT).

详细描述

Residents of Southeast Minnesota over 75 years of age with an inpatient or outpatient diagnosis of moderate or severe aortic stenosis will be consecutively identified using an automated bi-weekly review of the echo lab calendar (on Mondays and Fridays) at Mayo Clinic Rochester (MCR) and Mayo Clinic Health System (MCHS) sites. Participants will be consented to undergo venipuncture, urine collection and 99mTc-PYP SPECT/CT imaging to rule in/out the diagnosis of TTR-CA. Hence, the prevalence of TTR-CA will be defined. To place this prevalence in perspective of the global aortic stenosis cohort in the community, a rigorous screening log will be maintained to allow generation of a comprehensive CONSORT diagram. Importantly, baseline characteristics of patients who qualify for our study but decline to consent will still be collected provided that consent for use of their records for medical research had previously been granted.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
75 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Resident of Southeastern Minnesota (Olmsted, Dodge, Fillmore, Mower, Freeborn, Wabasha, or Steele County)
  • Age ≥ 75 years
  • Current diagnosis of moderate or severe aortic stenosis by most recent (within 6 months at most) echocardiogram as defined by:
  • Moderate AS: 1.0 cm2 < aortic valve area (AVA) ≤ 1.5 cm2
  • Severe AS: AVA ≤ 1.0 cm2

排除标准

  • Any cardiac surgery or major chest trauma within 4 weeks of PYP scan
  • Myocardial infarction within 4 weeks of PYP scan defined by typical angina, EKG changes and significant change in serial troponins. (Note that chronic troponin elevation is extremely common in cardiac amyloidosis).
  • Prior or current exposure to Plaquenil (Hydroxychloroquine)

研究组 & 干预措施

SPECT/CT

Other

99mTc-PYP single-photon positive emission computed tomography with computed tomography

干预措施: 99mTc-PYP (Drug)

结局指标

主要结局

Prevalence of TTR-CA in patients with moderate and severe aortic stenosis

时间窗: Baseline

Determine the prevalence of Transthyretin Cardiac Amyloidosis in a community based cohort of consecutive patients with moderate or severe aortic stenosis using 99mTc-Pyrophosphate (99mTc-PYP) single-photon positive emission computed tomography with computed tomography (SPECT/CT)

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Omar Abou Ezzeddine

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验